Coagulation and atherothrombotic disease
Authors:
- Ramzi AjjanRARamzi Ajjan
- Peter J. GrantPGPeter J. Grant
- 1 June 2006
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 186 (2) , 240-259
Abstract
No abstract availableKeywords
This publication has 198 references indexed in Scilit:
- Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activatorActa Diabetologica, 2005
- PPARγ and atherosclerosisCurrent Medical Research and Opinion, 2005
- Exercise and the endothelial cellInternational Journal of Cardiology, 2005
- Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive proteinInternational Journal of Cardiology, 2005
- Effects of atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery diseaseThe American Journal of Cardiology, 2004
- Inflammation, Immunity, and HMG-CoA Reductase InhibitorsCirculation, 2004
- Peroxisome Proliferator-Activated Receptor α Agonists Increase Nitric Oxide Synthase Expression in Vascular Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Modulating atherosclerosis through inhibition or blockade of angiotensinClinical Cardiology, 2003
- Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery DiseaseCirculation, 2003
- Allelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion eventHuman Genetics, 1992